负面影响电路子类型和神经,行为和情感对MDMA的反应:一个随机临床试验
Xue Zhang1, Laura M Hack1,2, Claire Bertrand1
1Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California.
JAMA network open
|April 30, 2025
概括
3,4-甲基二氧化甲胺 (MDMA) 在桃体反应性较高的个体中使负面影响回路正常化. 这种神经成像方法可以指导个性化MDMA疗法治疗PTSD等疾病.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 3,4-甲基二氧化甲胺 (MDMA) 在治疗创伤后应激障碍 (PTSD) 方面表现有前途.
- 确定从MDMA中获益最多的个体,并了解其神经机制是关键的研究差距.
- 通过神经电路配置来分层患者可以实现个性化的MDMA治疗策略.
研究的目的:
- 为了确定基线负面影响电路形状,特别是对无意识的威胁刺激的反应,是否可以区分对MDMA的急性反应.
- 研究神经成像生物标志物的潜力,以预测MDMA治疗结果.
主要方法:
- 进行了一项随机,双盲,参与者内部,安慰剂控制的临床试验.
- 患有下值创伤后应激障碍症状和早期创伤的参与者接受了功能磁共振成像 (fMRI) 评估负面影响电路.
- 分层是基于桃体对无意识威胁刺激 (NTN任务) 的基线反应性.
主要成果:
- 参与者被分为高 (NTNA+) 和低 (NTNA-) 杏仁体反应活性子组.
- 与NTNA-亚组相比,NTNA+亚组在使用MDMA后显示了杏仁体和前带皮层 (sgACC) 活动的显著减少.
- 在NTNA+组中,MDMA还增加了sgACC-杏仁体连接性和威胁表达的可喜.
结论:
- 在基线杏仁体反应性升高的个体中,MDMA急性正常化的负面影响电路反应性.
- 神经成像可以确定基于MDMA的个性化疗法的潜在生物标志物.
- 这项研究强调了MDMA辅助治疗精神疾病中的精准医学的潜力.
更多相关视频
09:16A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
15.1K
09:29Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
2.1K
相关概念视频
01:22CNS Stimulants: Psychedelic Agents
114
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
114
01:15Drug Abuse and Addiction: Pharmacological Phenomena
420
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
420
01:30Attention-Deficit/Hyperactivity Disorder
34
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
34